Latest Ratios: P/E Ratio -24.5x · EV/EBITDA 2.3x · ROE -9.6%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $73M | $72M | $42M | $52M | $162M | $653M | — | — | — |
| Enterprise Value | $59M | $59M | $44M | $51M | $128M | $556M | — | — | — |
| P/E Ratio → | -24.49 | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.29 | 0.29 | 0.10 | 0.10 | 0.23 | 0.75 | — | — | — |
| P/B Ratio | 2.23 | 2.31 | 1.49 | 0.62 | 0.76 | 1.69 | — | — | — |
| P/FCF | 4.19 | 4.16 | — | — | — | — | — | — | — |
| P/OCF | 3.34 | 3.32 | 16.37 | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.23 | 0.11 | 0.10 | 0.19 | 0.64 | — | — | — |
| EV / EBITDA | 2.31 | 2.30 | — | — | — | — | — | — | — |
| EV / EBIT | 7.38 | 7.33 | — | — | — | — | — | — | — |
| EV / FCF | — | 3.38 | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.0% | 73.0% | 68.6% | 61.3% | 53.4% | 62.4% | 71.1% | 72.2% | 71.0% |
| Operating Margin | 3.2% | 3.2% | -15.8% | -26.7% | -29.3% | -34.0% | -0.7% | 2.5% | 0.8% |
| Net Profit Margin | -1.1% | -1.1% | -17.1% | -29.0% | -28.1% | -26.1% | -2.5% | 4.3% | -2.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -9.6% | -9.6% | -129.2% | -103.7% | -65.1% | -94.2% | -23.0% | 47.2% | -43.9% |
| ROA | -1.8% | -1.8% | -31.7% | -42.4% | -35.9% | -46.0% | -6.6% | 11.9% | -8.6% |
| ROIC | 24.8% | 24.8% | -88.0% | -81.3% | -65.3% | -119.7% | -5.2% | 26.0% | 35.3% |
| ROCE | 14.9% | 14.9% | -83.5% | -76.1% | -61.6% | -110.6% | -4.7% | 17.3% | 6.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.81 | 0.81 | 0.80 | 0.40 | 0.22 | 0.02 | 0.42 | 0.58 | 0.50 |
| Debt / EBITDA | 0.99 | 0.99 | — | — | — | — | 1.10 | 0.79 | 0.38 |
| Net Debt / Equity | — | -0.43 | 0.08 | -0.01 | -0.16 | -0.25 | -0.15 | 0.10 | -0.74 |
| Net Debt / EBITDA | -0.53 | -0.53 | — | — | — | — | -0.40 | 0.14 | -0.57 |
| Debt / FCF | — | -0.78 | — | — | — | — | -0.65 | 0.49 | -0.92 |
| Interest Coverage | 1.61 | 1.61 | -9.38 | -16.20 | -57.56 | -454.08 | -10.69 | 24.93 | 1.43 |
Net cash position: cash ($39M) exceeds total debt ($25M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.74 | 0.74 | 0.62 | 0.72 | 1.01 | 1.27 | 0.77 | 0.79 | 0.85 |
| Quick Ratio | 0.63 | 0.63 | 0.49 | 0.57 | 0.72 | 0.71 | 0.47 | 0.54 | 0.64 |
| Cash Ratio | 0.45 | 0.45 | 0.16 | 0.20 | 0.43 | 0.44 | 0.26 | 0.26 | 0.42 |
| Asset Turnover | — | 1.71 | 2.40 | 1.90 | 1.56 | 1.37 | 2.42 | 2.60 | 3.16 |
| Inventory Turnover | 7.22 | 7.22 | 8.06 | 8.17 | 5.97 | 2.48 | 3.82 | 5.29 | 6.72 |
| Days Sales Outstanding | — | 1.65 | 1.26 | 0.88 | 0.46 | 0.51 | 0.36 | 0.73 | 1.18 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 21.8% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | 23.9% | 24.0% | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $7M | $7M | $6M | $6M | $6M | $6M | $1M | $1M |
Structural revenue decay
Based on current market data, BODI trades at a P/S ratio of 0.29, which suggests that investors are heavily discounting the company's future revenue potential compared to historical norms and broader industry peers, likely due to the persistent 39.89% revenue contraction observed in recent TTM financial reporting.
The negative P/E of -24.68 and the low EV/EBITDA of 2.34 indicate that the market is pricing the company as a distressed asset rather than a growth-oriented fitness platform. This valuation implies that the market expects further top-line erosion, and investors should monitor whether the current price-to-sales multiple represents a value opportunity or a value trap given the ongoing subscriber churn.
According to recent financial statements, ROIC has experienced extreme volatility, swinging from a peak of 36.1% in 2025Q4 to a negative 4.8% in 2025Q2, which highlights the difficulty of generating sustainable returns on invested capital while the core business model undergoes a significant and painful structural downsizing.
The erratic nature of ROIC suggests that the company's capital allocation has been ineffective at stabilizing returns during the revenue decline. Investors should interpret these fluctuations as a sign that the business lacks a stable moat to protect its margins, making long-term compounding of capital appear unlikely under the current operational framework.
As reported in quarterly filings, the cash conversion cycle has fluctuated significantly, reaching 47 days in 2025Q3, which indicates that the company's ability to efficiently manage its inventory and receivables is being hampered by the broader decline in demand for its nutrition and fitness product offerings.
The DIO (Days Inventory Outstanding) remaining elevated in the 50-60 day range suggests that the company may be struggling to clear physical stock, which could lead to future inventory write-downs. This inefficiency in working capital management further pressures liquidity and limits the company's ability to pivot toward a more capital-light digital-only model.
Based on reported figures, the debt-to-EBITDA ratio has shown extreme instability, spiking to 10.01 in 2025Q1, which suggests that despite a relatively low debt-to-equity ratio of 0.81, the company's ability to service its obligations is highly sensitive to the ongoing volatility in its operating earnings.
While the low debt-to-equity ratio provides a temporary buffer, the negative interest coverage ratios seen in several recent quarters indicate that the company is not consistently generating enough operating income to cover its interest expenses. This warrants further investigation into the company's long-term solvency if revenue trends do not stabilize.
The P/E ratio is frequently misapplied to BODI, as the company's heavy reliance on non-cash depreciation and amortization charges, alongside volatile restructuring costs, renders GAAP earnings a poor proxy for the underlying cash-generating capacity of the digital subscription business model.
Investors should instead focus on EV/Sales or free cash flow yield, as these metrics better capture the value of the company's recurring subscription revenue and the potential for a leaner cost structure. Relying on P/E in this context obscures the true operational health of the business by focusing on accounting noise rather than cash flow sustainability.
Includes 30+ ratios · 8 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BODI stock.
The Beachbody Company, Inc.'s current P/E ratio is -24.5x. This places it at the 50th percentile of its historical range.
The Beachbody Company, Inc.'s current EV/EBITDA is 2.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 2.3x.
The Beachbody Company, Inc.'s return on equity (ROE) is -9.6%. The historical average is -52.7%.
Based on historical data, The Beachbody Company, Inc. is trading at a P/E of -24.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
The Beachbody Company, Inc. has 73.0% gross margin and 3.2% operating margin.
The Beachbody Company, Inc.'s Debt/EBITDA ratio is 1.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.